What Are the Symptoms of Skin Cancer?

Translate to Spanish or other 102 languages!

Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma. Image for illustration purposes
Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma. Image for illustration purposes

Mega Doctor News

- Advertisement -

CDC – A change in your skin is the most common sign of skin cancer. This could be a new growth, a sore that doesn’t heal, or a change in a mole Not all skin cancers look the same.

For melanoma specifically, a simple way to remember the warning signs is to remember the A-B-C-D-Es of melanoma—

  1. Asymmetrical: Does the mole or spot have an irregular shape with two parts that look very different?
  2. Border: Is the border irregular or jagged?
  3. Color: Is the color uneven?
  4. Diameter: Is the mole or spot larger than the size of a pea?
  5. Evolving: Has the mole or spot changed during the past few weeks or months?

Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma.

- Advertisement -

More Information

Information Source:  CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -